-
1
-
-
0347122086
-
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
-
Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-2751.
-
(2003)
Crit Care Med
, vol.31
, pp. 2742-2751
-
-
Garnacho-Montero, J.1
Garcia-Garmendia, J.L.2
Barrero-Almodovar, A.3
-
2
-
-
0038555339
-
Community-acquired bloodstream infection in critically ill adult patients: Impact of shock and inappropriate antibiotic therapy on survival
-
Vallé s J, Rello J, Ochagavá A, et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123:1615-1624.
-
(2003)
Chest
, vol.123
, pp. 1615-1624
-
-
Vallé, S.J.1
Rello, J.2
Ochagavá, A.3
-
3
-
-
38349108756
-
Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study
-
Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study. J Antimicrob Chemother 2008; 61:436-441.
-
(2008)
J Antimicrob Chemother
, vol.61
, pp. 436-441
-
-
Garnacho-Montero, J.1
Ortiz-Leyba, C.2
Herrera-Melero, I.3
-
4
-
-
84869016925
-
Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality
-
Edusepsis Study Group
-
Dáz-Martń A, Martńez-Gonzá lezML, Ferrer R, et al., Edusepsis Study Group. Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care 2012; 16:R223.
-
(2012)
Crit Care
, vol.16
, pp. R223
-
-
Dáz-Martń, A.1
Martńez-Gonzá Lez, M.L.2
Ferrer, R.3
-
5
-
-
13644269309
-
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia
-
American Thoracic Society/Infectious Diseases Society of America
-
American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 388-416
-
-
-
6
-
-
84873339299
-
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
-
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013; 41:580-637.
-
(2013)
Crit Care Med
, vol.41
, pp. 580-637
-
-
Dellinger, R.P.1
Levy, M.M.2
Rhodes, A.3
-
7
-
-
84889824250
-
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia
-
ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN
-
Averbuch D, Orasch C, Cordonnier C, et al., ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013; 98:1826-1835.
-
(2013)
Haematologica
, vol.98
, pp. 1826-1835
-
-
Averbuch, D.1
Orasch, C.2
Cordonnier, C.3
-
8
-
-
78650166326
-
De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medicosurgical intensive care unit
-
Morel J, Casoetto J, Jospé R, et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medicosurgical intensive care unit. Crit Care 2010; 14:R225.
-
(2010)
Crit Care
, vol.14
, pp. R225
-
-
Morel, J.1
Casoetto, J.2
Jospé, R.3
-
9
-
-
84860226563
-
Antibiotic strategies in severe nosocomial sepsis: Why do we not deescalate more often?
-
Heenen S, Jacobs F, Vincent J-L. Antibiotic strategies in severe nosocomial sepsis: why do we not deescalate more often? Crit Care Med 2012; 40:1404-1409.
-
(2012)
Crit Care Med
, vol.40
, pp. 1404-1409
-
-
Heenen, S.1
Jacobs, F.2
Vincent, J.-L.3
-
10
-
-
84905972598
-
Development of an antibiotic spectrum score based on Veterans Affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: A modified Delphi approach
-
Madaras-Kelly K, Jones M, Remington R, et al. Development of an antibiotic spectrum score based on Veterans Affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: A modified Delphi approach. Infect Control Hosp Epidemiol 2014; 35:1103-1113.
-
(2014)
Infect Control Hosp Epidemiol
, vol.35
, pp. 1103-1113
-
-
Madaras-Kelly, K.1
Jones, M.2
Remington, R.3
-
11
-
-
78049522796
-
Long-term impacts of antibiotic exposure on the human intestinal microbiota
-
Jernberg C, Lö fmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156:3216-3223.
-
(2010)
Microbiology
, vol.156
, pp. 3216-3223
-
-
Jernberg, C.1
Lö Fmark, S.2
Edlund, C.3
Jansson, J.K.4
-
12
-
-
84891026537
-
Deescalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
-
Garnacho-Montero J, Gutié rrez-Pizarraya A, Escoresca-Ortega A, et al. Deescalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014; 40:32-40.
-
(2014)
Intensive Care Med
, vol.40
, pp. 32-40
-
-
Garnacho-Montero, J.1
Gutié Rrez-Pizarraya, A.2
Escoresca-Ortega, A.3
-
13
-
-
8544252455
-
De-escalation therapy in ventilatorassociated pneumonia
-
Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilatorassociated pneumonia. Crit Care Med 2004; 32:2183-2190.
-
(2004)
Crit Care Med
, vol.32
, pp. 2183-2190
-
-
Rello, J.1
Vidaur, L.2
Sandiumenge, A.3
-
14
-
-
67649639469
-
Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
-
Eachempati SR, Hydo LJ, Shou J, Barie PS. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma 2009; 66:1343-1348.
-
(2009)
J Trauma
, vol.66
, pp. 1343-1348
-
-
Eachempati, S.R.1
Hydo, L.J.2
Shou, J.3
Barie, P.S.4
-
15
-
-
79952095005
-
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
-
Joung MK, Lee JA, Moon SY, et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care 2011; 15:R79.
-
(2011)
Crit Care
, vol.15
, pp. R79
-
-
Joung, M.K.1
Lee, J.A.2
Moon, S.Y.3
-
16
-
-
33646471520
-
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia
-
Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210-1218.
-
(2006)
Chest
, vol.129
, pp. 1210-1218
-
-
Kollef, M.H.1
Morrow, L.E.2
Niederman, M.S.3
-
17
-
-
34548164363
-
De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
-
Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007; 33:1533-1540.
-
(2007)
Intensive Care Med
, vol.33
, pp. 1533-1540
-
-
Giantsou, E.1
Liratzopoulos, N.2
Efraimidou, E.3
-
18
-
-
34247551035
-
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study
-
ADANN Study Group
-
Alvarez-Lerma F, Alvarez B, Luque P, et al., ADANN Study Group. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study. Crit Care 2006; 10:R78.
-
(2006)
Crit Care
, vol.10
, pp. R78
-
-
Alvarez-Lerma, F.1
Alvarez, B.2
Luque, P.3
-
19
-
-
84901602158
-
Bloodstreaminfectionsandsepsis inGreece: Over-time changeofepidemiology and impact of de-escalation on final outcome
-
Hellenic Sepsis Study Group
-
Koupetori M, Retsas T, Antonakos N, et al., Hellenic Sepsis Study Group. Bloodstreaminfectionsandsepsis inGreece: over-time changeofepidemiology and impact of de-escalation on final outcome. BMC Infect Dis 2014; 14:272.
-
(2014)
BMC Infect Dis
, vol.14
, pp. 272
-
-
Koupetori, M.1
Retsas, T.2
Antonakos, N.3
-
20
-
-
84891001182
-
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: Results from an observational study
-
Mokart D, Slehofer G, Lambert J, et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: Results from an observational study. Intensive Care Med 2014; 40:41-49.
-
(2014)
Intensive Care Med
, vol.40
, pp. 41-49
-
-
Mokart, D.1
Slehofer, G.2
Lambert, J.3
-
21
-
-
84862812810
-
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: A randomized clinical trial
-
Kim JW, Chung J, Choi SH, et al. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: A randomized clinical trial. Crit Care 2012; 16:R28.
-
(2012)
Crit Care
, vol.16
, pp. R28
-
-
Kim, J.W.1
Chung, J.2
Choi, S.H.3
-
22
-
-
84919392230
-
Deescalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial
-
AZUREA Network Investigators
-
Leone M, Bechis C, Baumstarck K, et al., AZUREA Network Investigators. Deescalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial. Intensive Care Med 2014; 40:1399-1408.
-
(2014)
Intensive Care Med
, vol.40
, pp. 1399-1408
-
-
Leone, M.1
Bechis, C.2
Baumstarck, K.3
-
23
-
-
84880022981
-
Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients
-
Gonzalez L, Cravoisy A, Barraud D, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care 2013; 17:R140.
-
(2013)
Crit Care
, vol.17
, pp. R140
-
-
Gonzalez, L.1
Cravoisy, A.2
Barraud, D.3
-
24
-
-
0033504530
-
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillinresistant and methicillin-susceptible organisms
-
Gonzá lez C, Rubio M, Romero-Vivas J, et al. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillinresistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-1177.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 1171-1177
-
-
Gonzá Lez, C.1
Rubio, M.2
Romero-Vivas, J.3
-
25
-
-
79955673698
-
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
-
Paul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 2011; 17:1581-1586.
-
(2011)
Clin Microbiol Infect
, vol.17
, pp. 1581-1586
-
-
Paul, M.1
Zemer-Wassercug, N.2
Talker, O.3
-
26
-
-
84904564775
-
Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia
-
Foo H, Chater M, Maley M, van Hal SJ. Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia. J Antimicrob Chemother 2014; 69:2252-2257.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 2252-2257
-
-
Foo, H.1
Chater, M.2
Maley, M.3
Van Hal, S.J.4
-
27
-
-
4043059435
-
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
-
Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004; 4:519-527.
-
(2004)
Lancet Infect Dis
, vol.4
, pp. 519-527
-
-
Safdar, N.1
Handelsman, J.2
Maki, D.G.3
-
28
-
-
34547700428
-
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy
-
Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007; 35:1888-1895.
-
(2007)
Crit Care Med
, vol.35
, pp. 1888-1895
-
-
Garnacho-Montero, J.1
Sa-Borges, M.2
Sole-Violan, J.3
-
29
-
-
84879413256
-
Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: A post hoc analysis of a prospective cohort
-
Spanish Network for Research in Infectious Diseases (REIPI)
-
Peñ a C, Suarez C, Ocampo-Sosa A, et al., Spanish Network for Research in Infectious Diseases (REIPI). Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: A post hoc analysis of a prospective cohort. Clin Infect Dis 2013; 57:208-216.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 208-216
-
-
Peñ, A.C.1
Suarez, C.2
Ocampo-Sosa, A.3
-
30
-
-
84910013793
-
Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort
-
GEIH/REIPIAb2010 Group
-
Ló pez-Corté s LE, Cisneros JM, Fernández-Cuenca F, et al., GEIH/REIPIAb2010 Group. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort. J Antimicrob Chemother 2014; 69:3119-3126.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 3119-3126
-
-
Ló Pez-Corté, S.L.E.1
Cisneros, J.M.2
Fernández-Cuenca, F.3
-
31
-
-
84866072596
-
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae: Importance of combination therapy
-
Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55:943-950.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 943-950
-
-
Tumbarello, M.1
Viale, P.2
Viscoli, C.3
-
32
-
-
82955233374
-
Imipenem: A potent inducer of multidrug resistance in Acinetobacter baumannii
-
Kuo HY, Chang KC, Kuo JW, et al. Imipenem: A potent inducer of multidrug resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2012; 39:33-38.
-
(2012)
Int J Antimicrob Agents
, vol.39
, pp. 33-38
-
-
Kuo, H.Y.1
Chang, K.C.2
Kuo, J.W.3
-
33
-
-
78649451111
-
De-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality?
-
De Waele JJ, Ravyts M, Depuydt P, et al. De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care 2010; 25:641-646.
-
(2010)
J Crit Care
, vol.25
, pp. 641-646
-
-
De Waele, J.J.1
Ravyts, M.2
Depuydt, P.3
-
34
-
-
71249146783
-
Introduction of ertapenem into a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa
-
Goldstein EJ, Citron DM, Peraino V, et al. Introduction of ertapenem into a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53:5122.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 5122
-
-
Goldstein, E.J.1
Citron, D.M.2
Peraino, V.3
-
35
-
-
84867709158
-
ESCMID- guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients
-
ESCMID Fungal Infection Study Group
-
Cornely OA, Bassetti M, Calandra T, et al., ESCMID Fungal Infection Study Group. ESCMID- guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 (Suppl 7):19-37.
-
(2012)
Clin Microbiol Infect
, vol.18
, pp. 19-37
-
-
Cornely, O.A.1
Bassetti, M.2
Calandra, T.3
-
36
-
-
77957662332
-
Practice patterns for antibiotic deescalation in culture-negative healthcare-associated pneumonia
-
Schlueter M, James C, Dominguez A, et al. Practice patterns for antibiotic deescalation in culture-negative healthcare-associated pneumonia. Infection 2010; 38:357-362.
-
(2010)
Infection
, vol.38
, pp. 357-362
-
-
Schlueter, M.1
James, C.2
Dominguez, A.3
-
37
-
-
84874095242
-
A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia
-
Boyce JM, Pop OF, Abreu-Lanfranco O, et al. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother 2013; 57:1163-1168.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 1163-1168
-
-
Boyce, J.M.1
Pop, O.F.2
Abreu-Lanfranco, O.3
|